Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention

Julio Avelar-Barragan1, Laura F Mendez Luque2, Jenny Nguyen3

  • 1Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California, USA.

Mbio
|October 25, 2023
PubMed
Abstract

Insights

This study explored the gut microbiome's link to inflammation in myeloproliferative neoplasms (MPN) patients following Mediterranean or standard diets. While diet didn't alter the microbiome, specific gut bacteria were associated with inflammation levels.

Area of Science:

  • Microbiome research
  • Inflammation and chronic disease
  • Gastroenterology

Background:

  • The gut microbiome acts as a crucial mediator between diet and host health.
  • Inflammation is a significant factor in myeloproliferative neoplasms (MPN).
  • The Mediterranean (MED) diet is recognized for its anti-inflammatory properties.

Purpose of the Study:

  • To investigate longitudinal changes in the gut microbiome of MPN patients.
  • To assess the impact of Mediterranean versus standard dietary counseling on the gut microbiome and inflammation.
  • To identify potential microbiome-associated mechanisms influencing inflammation in MPN.

Main Methods:

  • Longitudinal characterization of gut microbiomes in MPN patients.
  • Dietary counseling based on Mediterranean or 2020 US Guidelines for Americans.
  • Analysis of associations between gut microbiome composition and inflammation markers.

Main Results:

  • No significant alterations in the gut microbiome were observed in response to either dietary intervention.
  • Several associations were identified between specific gut microbiome profiles and inflammation levels in MPN patients.
  • The study did not establish a direct causal link between the dietary interventions and microbiome changes.

Conclusions:

  • Dietary interventions did not significantly shift the gut microbiome in MPN patients during the study period.
  • The gut microbiome composition is associated with inflammation in MPN, suggesting potential therapeutic targets.
  • Further research is warranted to elucidate the mechanistic links between the MPN gut microbiome and inflammation.